Jubilant Life Sciences has raised Rs 350 crore through non-convertible debentures (NCDs) on private placement basis. The company has issued 3,500 NCDs of Rs 10 lakh each for cash at par on September 5, 2018. NCDs are proposed to be listed on National Stock Exchange of India.
Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.